-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
December 01, 2012 - What is the effectiveness of surgical therapies
(one-stage vs. two-stage, laparoscopic vs. open approach … Eleven
studies reported outcomes following either one-stage
FS orchiopexy, two-stage FS orchiopexy, … This study had a testicular descent
rate of 63 percent for one-stage FS, 67.6 percent for two-
stage … Primary orchiopexy had higher strength of evidence than
one-stage and two-stage procedures based on … Current literature lacks assessment of whether a one-
stage or two-stage method for the FS approach to
-
effectivehealthcare-admin.ahrq.gov/health-topics/blood-disorders
July 26, 2016 - Archived January 14, 2013
Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage … Archived October 12, 2012
Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage … Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage … Protocol Archived August 29, 2011
Laboratory Biomarkers for Iron Deficiency Anemia in Late Stage … Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in End-Stage
-
effectivehealthcare-admin.ahrq.gov/products/care-interventions-pwd/protocol
August 01, 2020 - For this review, we will be guided by the NIH Stage Model for Behavioral Interventions. 12 The NIH stage … 0) to new intervention creation (stage 1), research-setting efficacy (stage 2), "real-world" community-clinic … efficacy (stage 3), broad community-based effectiveness (stage 4), to eventually dissemination and implementation … research (stage 5). … NIH Stage 3 or 4 intervention.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pwd-care-interventions-protocol.pdf
February 22, 2019 - For this review, we will be guided by the NIH Stage Model for Behavioral Interventions.
12 The NIH stage … 0) to new intervention creation
(stage 1), research-setting efficacy (stage 2), “real-world” community-clinic … efficacy
(stage 3), broad community-based effectiveness (stage 4), to eventually dissemination
and … implementation research (stage 5). … NIH Stage 3 or 4 intervention.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/deliberative-methods-facilitation-slides-text.pdf
January 11, 2017 - training manual
o Remains flexible
Slide 25
Facilitation tools: Ice breakers
• Ice breakers
o Stage … 1: Getting to know you
o Stage 2: Understanding the process
o Stage 3: Creating a community
Slide … 26
Facilitation tools: Ice breakers
• Ice breakers
o Stage 1: Getting to know you
Image: There … Slide 27
Facilitation tools: Ice breakers
• Ice breakers
o Stage 2: Understanding the process
Image … Slide 28
Facilitation tools: Ice breakers
• Ice breakers
o Stage 3: Creating a community
Image
-
effectivehealthcare-admin.ahrq.gov/products/cancer-pancreas/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/health-topics/anemia
October 12, 2012 - Archived October 12, 2012
Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage … Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage … Protocol Archived August 29, 2011
Laboratory Biomarkers for Iron Deficiency Anemia in Late Stage … Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in End-Stage
-
effectivehealthcare-admin.ahrq.gov/products/chronic-kidney-disease-anemia-2011/research
December 01, 2019 - Reports
Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage … Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage … We considered studies of pediatric and adult nondialysis patients with stage 3, 4, or 5 CKD, patients … Project Timeline
Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic … Systematic Review:
Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
August 09, 2013 - Once
pancreatic adenocarcinoma is diagnosed, the stage of disease is a key determinant of clinical … • We added the precise stage (stage IA, IB, IIA, IIB, III, or IV) to KQ 2 (staging) because
some … studies may report accuracy data based on stage (e.g., percentage of tumors judged
to be stage IB by … imaging and were later found to be stage IB during surgery) … • N stage
• M stage
• Stage I, II, III, or IV
• Vessel involvement
• Resectability
2b P2 Same
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
April 01, 2010 - In the first stage, one estimates the parameters in (2)
by least squares. … exposure with its predicted value from the first stage. … If no covariates
are included in the first- and second-stage models, then two-stage least squares estimation … model.
10,11
Therefore, adding weak instruments to the
first stage can increase bias. … Was breast conserving surgery underutilized
for early stage breast cancer?
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-protocol.pdf
June 05, 2024 - organ-specific
definition of late stage); distribution of cancer stage at
diagnosis (i.e., stage shift … I N Text
Stage I % Text
Stage I comments Text
Stage II N Text
Stage II % Text … Stage II comments Text
Stage III N Text
Stage III % Text
Stage III comments Text … Stage IV N Text
Stage IV % Text
Stage IV comments Text
Stage missing N Text
55 … Stage not reported N Text
Stage not reported % Text
Stage not reported comments Text
Total
-
effectivehealthcare-admin.ahrq.gov/products/cell-free-dna/protocol
July 01, 2024 - organ-specific definition of late stage); distribution of cancer stage at diagnosis (i.e., stage shift … I N Text Stage I % Text Stage I comments Text Stage II N Text Stage II % Text Stage II comments … Text Stage III N Text Stage III % Text Stage III comments Text Stage IV N Text Stage IV % … Text Stage IV comments Text Stage missing N Text Stage missing % Text Stage missing comments … Text Stage not reported N Text Stage not reported % Text Stage not reported comments Text Total
-
effectivehealthcare-admin.ahrq.gov/health-topics/healthy-sleep
During sleep, your brain cycles through five stages: stage 1, 2, 3, 4, and rapid eye movement (REM) sleep … Different things happen during each stage. … people age, however, they often get less sleep or they tend to spend less time in the deep, restful stage
-
effectivehealthcare-admin.ahrq.gov/products/renal-cancer/research-protocol
December 01, 2019 - Localized renal cell carcinoma (stage T1N0M0, ≤ 7 cm in diameter; stage T2N0M0, > 7 cm in diameter) have … Given the increased incidence in early, low-stage tumors without improvement in cancer-related deaths … T1, and > 85% for stage T2 tumors). … I and II renal cell carcinoma, which corresponds to clinical stage T1 (<7 cm, organ confined) or T2 … Kane, C.J., et al., Renal cell cancer stage migration: analysis of the National Cancer Data Base.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-pancreas_disposition-comments.pdf
September 23, 2014 - Peer Reviewer 2 Discussion EUS is clearly superior in T stage assessment. … Trying to define T stage is useless. … About T
stage, we included it only because it was one facet
of clinical stage, even though its importance … For each stage of care, appropriate
testing and treatment are outlined. … We also concluded “US-FNA
is more accurate than MDCT in the assessment of
the T stage of pancreatic
-
effectivehealthcare-admin.ahrq.gov/products/treatment-outcomes-chronic-kidney/rapid-research
October 01, 2024 - CKD stage 4 represents severe kidney damage. … CKD stage 5, representing severe kidney damage or failing kidneys and also termed as end stage kidney … Treatment for CKD stage 5 patients is dialysis or kidney replacement therapy. … Protocols for Treating Patients with End‐stage Renal Disease: A Survey of AEGD/GPR Dental Residencies … Protocols for Treating Patients with End‐stage Renal Disease: A Survey of Nephrology Fellowships.
-
effectivehealthcare-admin.ahrq.gov/products/liver-cancer/research-protocol
December 01, 2019 - all individuals with other causes for cirrhosis (including alcoholic cirrhosis), and patients with stage … There is clinical uncertainty about which imaging technique to use to diagnose and stage HCC. … What is the comparative test performance of imaging techniques to predict HCC tumor stage? … Key Question 3
Diagnostic outcomes include:
Measures for stage-specific accuracy of imaging ( … Frequency of various tumor stages and stage-appropriate treatment provided, conditional on diagnosis
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/facilitation-webcast-slides.pptx
June 13, 2013 - Typical comments at this stage: I don’t think that’s the case, its their own fault, we should not be … examples, and refining questions to get at the deeper tensions within an issue.
24
Ice breakers
Stage … 1: Getting to know you
Stage 2: Understanding the process
Stage 3: Creating a community
Facilitation … 1: Getting to know you
Stage 2: Understanding the process and
Stage 3: Creating a community
25
Ice … Strip
Panel 3 Panel 4
Community Forum
Community Forum
Community Forum
During stage
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-conventional-ct-mdct-including-virtual-ct-bronchoscopy-petpet-ct-and-mri-for-the-diagnosis-or-pretreatment-staging-of-small-cell-and-non-small-cell-lung-cancer
November 01, 2017 - (For example, an ethnic group, stage or severity of a disease.)
-
effectivehealthcare-admin.ahrq.gov/health-topics/dialysis
January 24, 2012 - Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage … Protocol Archived August 29, 2011
Laboratory Biomarkers for Iron Deficiency Anemia in Late Stage … Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in End-Stage